Health News

New data released demonstrates that the addition of Zometa (zoledronic acid) injection to standard chemotherapy before breast cancer surgery reduces the size of breast tumors more effectively than chemotherapy alone in women with early-stage disease.

Read more

Filed under: General Health News
Tags: Breast Cancer, cancer, General Health News, Surgery, Tumor

Related posts

• Study examines risk factors for cancer in unaffected breast of breast cancer patients (0)
  (American Cancer Society) A new study identifies certain patient and tumor characteristics that may help indicate which breast cancer patients would be the most likely to benefit from preventive surgery to remove the unaffected breast. Read more [tags] General Health News [/tags]
  
  
• Two new compounds show promise for eliminating breast cancer tumors (0)
  (University of Central Florida) Two new compounds created by a University of Central Florida professor show early promise for destroying breast cancer tumors. Researchers have observed no negative side effects so far. Read more [tags] General Health News [/tags]
  
  
• Therapy targeting cyclin D1 protein may block expansion of breast cancer cells (0)
  Breast cancer stem cells are known to be involved in therapy resistance and the recurrence of cancerous tumors. Read more [tags] General Health News [/tags]
  
  
• Therapy may block expansion of breast cancer cells (0)
  (Wiley-Blackwell) Breast cancer stem cells are known to be involved in therapy resistance and the recurrence of cancerous tumors. A new study appearing in Clinical and Translational Science shows the mechanisms governing stem cell expansion in breast cancer (called Notch activity), and finds that therapy targeting a protein called cyclin D1 may block the expansion [...]
  
  
• Study shows surgery provides good long-term outcomes for patients with gastrointestinal cancers (0)
  (Weber Shandwick Worldwide) New research published in the January issue of the Journal of the American College of Surgeons shows that laparoscopic removal of gastrointestinal stromal tumors is safe and effective, with a disease-free survival rate of nearly 80 percent after an average follow-up time of three and a half years. Read more [tags] General Health News [...]